Biotechnology Stocks I Performance Guide: Viking Therapeutics, Inc. (VKTX)
VKTX has no dividends
Table and Chart of VKTX Performance
See what a $1,000 investment in VKTX is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| VKTX Returns | |
|---|---|
| Start Date | May-29-2015 |
| Start Price | $8.23 |
| End Date | Dec-01-2023 |
| End Price | $13.01 |
| # Prices | 104 |
| Min Date | Aug-31-2017 |
| Min Price | $1.04 |
| Max Date | May-31-2023 |
| Max Price | $21.96 |
| Total Return | 58.08% |
| Annualized Return | 5.43% |
| Current Value of $1,000 Purchase | $1,581 |
| Number Returns | 5,356 |
| Average Return | 165.11% |
| Number Profitable Returns | 3,350 |
| Percent Profitable Returns | 62.55% |
| Number Unprofitable Returns | 2,006 |
| Percent Unprofitable Returns | 37.45% |
| Profitable to Unprofitable Returns Ratio | 1.67 |
| VKTX Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $1,301,377,000 | Price to Sales |
| Earnings per Share | $-0.9200 |
| PE Ratio | None |
| PE to Growth Ratio | -0.03 |
| Price to Book | 3.534 |
| PRICE DATA | |
| 52 Week High | $25.72 |
| 52 Week Low | $3.54 |
| Analyst Target Price | $34 |
| 50-Day Moving Average | $10.89 |
| 200-Day Moving Average | $15.16 |
| FINANCIAL DATA | |
| Revenue per Share | $0 |
| Revenue | $0 |
| Profit Margin | 0% |
| Return on Equity | -0.311% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
VKTX Compare Returns with S&P 500
VKTX Trendline Chart